Today, Qlife disclosed its first collaboration since its new strategy of going to market with partners in June.
Qlife has restructured its operations, reducing its workforce considerably and terminating its leasing contract, so the fixed costs will be ...
Redeye endorses Qlife’s new strategy, which will allow life science companies to use Qlife’s platform, as a potentially quicker and more cos...
The main event since our last update is the conclusion of the rights issue in April.
The subscription rate of 31% is below average. However, thanks to the use of a top guarantee, 100% of the issue is covered.
Redeye comments on Qlife’s rights issue announced yesterday evening.
Redeye reviews Qlife’s fourth quarter report. After the end of the quarter, Qlife concluded its preparation for a soft launch of the Egoo sy...
Redeye initiates coverage of Qlife, which aims to bring clinical grade biomarker testing to the home setting thanks to its Egoo system.
